19th Annual International Myeloma Society Meeting

Cecilia BrownMyeloma | November 16, 2022
Doris Hansen, MD, of the Moffitt Cancer Center, spoke about the research during an oral abstract presentation at IMS.
Leah SherwoodMeeting News | November 22, 2022
Adding a monoclonal antibody to a triplet treatment significantly lowered the risk of disease...
Leah SherwoodMyeloma | May 12, 2023
A single infusion of ciltacabtagene autoleucel “resulted in deep and durable responses" in CARTITUDE-2’s cohort A.
Advertisement
Leah SherwoodMyeloma | November 16, 2022
The data were from the phase III DETERMINATION trial...
Leah SherwoodMyeloma | November 16, 2022
Carfilzomib, lenalidomide, and dexamethasone improved progression-free survival (PFS) over...
Cecilia BrownMeeting News | November 22, 2022
Adding ixazomib to pomalidomide and dexamethasone improved progression-free survival rates...
Advertisement
Advertisement
Advertisement